miR-122-5p通过靶向Circ_MTM1在HBV相关肝纤维化中的分子机制研究Molecular Mechanism of miR-122-5p in HBV-Associated Liver Fibrosis by Targeting Circ_MTM1
姚福纯, 李 彬, 蔡 艳, 黄俊文, 王振生, 王海鑫, 刘贵旻 科研立项经费支持
生物医学Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/HJBM.2024.141008, January 25 2024
APRI、FIB-4、RPR和GPR在慢性HBV感染诊断中的意义Significance of APRI, FIB-4, RPR and GPR in the Diagnosis of Chronic HBV Infection
严美红, 王亚平, 刘 营, 边 城
临床医学进展Vol.10 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2020.1012487, December 30 2020
乙肝“大三阳”和“小三阳”患者血清中HBV DNA载量、肝功能指标、肝纤维化标志物及肝癌标志物比较分析Comparison of HBV DNA Load, Liver Function Index, Liver Fibrosis Markers and Liver Cancer Markers between Hepatitis B Patients with HBsAg, HBeAg, and HBcAb Test Positive and HBsAg, HBeAb, and HBcAb Test Positive
潘晓娟, 吴胜军
临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281069, August 11 2022
利妥昔单抗联合化疗致HBsAg(-)/HBcAb(+)者HBV再激活1例并文献复习HBV Reactivation in Patients with HBsAg(-)/HBcAb(+) Induced by Rituximab Combined with Chemotherapy: A Case Report and Literature Review
宣碧碧, 边 城
临床医学进展Vol.11 No.11, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1111771, November 22 2021
HBV相关肝癌的CD8+T细胞抗肿瘤免疫机制研究进展Research Progress on Anti-Tumor Immune Mechanism of CD8+T Cells in HBV-Related Hepatocellular Carcinoma
任丹丹, 马金鑫
临床医学进展Vol.11 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.115338, May 27 2021
慢性HBV感染者基于聚乙二醇干扰素治疗研究进展Research Progress of Pegylated Interferon Therapy for Chronic HBV Infection
陈巧霞, 杨 恒
临床医学进展Vol.14 No.3, 全文下载: PDF HTML XML DOI:10.12677/acm.2024.143884, March 28 2024